Chinese research team achieves new breakthroughs in autoimmune hepatitis treatment

On March 26, People’s Finance reported that a Chinese research team recently made significant progress in the treatment of autoimmune hepatitis. A joint research team from Qilu Hospital of Shandong University and the School of Pharmacy of Shandong University proposed a new method based on in vivo cell reprogramming, providing new ideas for the treatment of autoimmune diseases. The related research results have been published in the international academic journal “Cell-Stem Cell.” (Xinhua News Agency)

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin